bucladesine has been researched along with Colorectal Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho-Chung, YS; Clair, T; Greiner, JW; Guadagni, F; Roselli, M; Schlom, J; Tortora, G | 1 |
| Endo, K; Hosono, M; Imai, K; Ishiwata, I; Kiyozuka, Y; Nakai, T; Saga, T; Sakahara, H; Watanabe, Y; Yachi, A | 1 |
2 other study(ies) available for bucladesine and Colorectal Cancer
| Article | Year |
|---|---|
Carcinoembryonic antigen regulation in human colorectal tumor cells by a site-selective cyclic AMP analogue: a comparison with interferon-gamma.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Antibodies, Monoclonal; Antineoplastic Agents; Bucladesine; Carcinoembryonic Antigen; Cell Line; Colonic Neoplasms; Colorectal Neoplasms; Dose-Response Relationship, Drug; Histocompatibility Antigens Class I; Humans; Interferon-gamma; Kinetics; Mice; Mice, Nude; Radioimmunoassay; Recombinant Proteins; Rectal Neoplasms; Transplantation, Heterologous | 1991 |
Drug effects on CA125 antigen expression and antibody binding to cancer cells.
Topics: Antibodies, Monoclonal; Antigens, Tumor-Associated, Carbohydrate; Binding Sites, Antibody; Bucladesine; Butyrates; Butyric Acid; Cell Line; Colorectal Neoplasms; Dexamethasone; Female; Humans; Interferon-gamma; Interleukin-2; Kinetics; Lung Neoplasms; Ovarian Neoplasms; Recombinant Proteins; Tumor Necrosis Factor-alpha | 1991 |